Navigation Links
Periodic in Biological Technology

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

... as well as other factors expressed from time to time in the Company's periodic filings with the SEC. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Zimmer Launches New Medical Education and BioSkills Training Program

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing

... as well as other factors expressed from time to time in the Company's periodic filings with the SEC. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

ArborGen and Senesco Announce Wood Quality Results

... AMEX, as well as other factors expressed from time to time in Senesco's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a result, this press release should be read in conjunction with Senesco's periodic filings with the SEC. The forward-looking statements contained herein are ...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a ... this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Poniard Pharmaceuticals Files Shelf Registration

... is intended to provide the Company with flexibility to facilitate the periodic sale of its securities, subject to market conditions and the Company's ... and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including ...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

United Therapeutics Reports First Quarter 2009 Financial Results

... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US

... on the Exchange during the plan period through June 23, 2010, subject to periodic review by the Exchange to determine if Palatin is making progress ... its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not ...

InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune Announces Issuance of U.S. Patent for ITMN-191

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a ... this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC. Completion of the offering is subject to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Palatin Technologies Receives Notification Letter from NYSE Alternext US

... its listing during the plan period through July 23, 2010, subject to periodic review by the Exchange to determine if it is making progress consistent ... its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not ...

Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths

... that the surface plasmon resonances of metal nanoparticles in a periodic array can have considerably narrower spectral widths than those of ... Further, as the optical fields are significantly more intense in a periodic array, the method could improve the sensitivity of detecting molecules at ...

InterMune Reports Third Quarter 2008 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

United Therapeutics Reports Third Quarter 2008 Financial Results

... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...

InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Watson Pharmaceuticals Reports Second Quarter 2008 Results

... mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net ... products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but ...

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

United Therapeutics Reports Second Quarter 2008 Financial Results

... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...

Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook

... mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net ... products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but ...

Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

Two-faced miniatures

... micrometers wide). The bottom portion of the device is a phase mask with a periodic surface structure. This arrangement is irradiated through a transparency ... with sides of 60 m. Once the parallel light rays pass through the strictly periodic surface structure of the phase mask, the result is a complex ...

Zimmer Announces Settlement of Federal Investigation

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...
Other Contents
(Date:9/29/2014)... Parents with children at home should use ventilation ... State University are recommending, after a new study showed ... asthma symptoms and chronic bronchitis. , "In homes where ... of asthma and wheezing is higher than in homes ... Ellen Smit, an associate professor in the College of ...
(Date:9/29/2014)... In order to support the world,s needs to ... and more, new and more efficient catalytic materials ... researchers, including several from Wayne State University, is ... new grant from the National Science Foundation. , ... of Multicomponent Materials for Electrocatalytic Cascade Reactions," was ...
(Date:9/29/2014)... Scientists at Washington State University have concluded that ... apples may help prevent disorders associated with ... to assess these compounds in apple cultivars grown ... edition of the journal Food Chemistry ., ... good source of these nondigestible compounds but there ...
Breaking Biology News(10 mins):Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3Wayne State research aims to develop new, more efficient catalytic materials 2An apple a day could keep obesity away 2
(Date:10/1/2014)... October 01, 2014 Today marks the ... Dental Art Institute in Oxnard and Woodland Hills, Calif., ... full mouth rehabilitation training. , “Speaking to this group ... transformative procedures to get the help and care they ... involve repairing previous dental work, providing cosmetic dentistry, correcting ...
(Date:10/1/2014)... October 01, 2014 After undergoing a ... chamber of commerce to join, Living Well Assisted Living ... Commerce in Marin County, the home of its headquarters. ... the moment, and the thought of adding one more ... to keep looking for the right chamber to join ...
(Date:10/1/2014)... is safer and more effective than intermediate-acting insulin ... new research published in the BMJ . ... doses of both long- and intermediate-acting insulin, ranking ... patients with Type 1 diabetes, we found that ... it came to controlling blood sugar, preventing weight ...
(Date:10/1/2014)... 01, 2014 The Oliver Law ... new Other-Sonic Ultrasound Gel lawsuit web page ... the litigation surrounding the 2011 Pseudomonas aeruginosa / ... Royal Oak, Michigan, which was ultimately traced to ... representing William Beaumont patients who allegedly became ill ...
(Date:10/1/2014)... 01, 2014 Industrial freezers ... out of 5, which indicates moderate negotiating power ... beverage manufacturers, food service businesses, healthcare facilities and ... these users' diversity, demand for industrial freezers increases ... production, consumer spending and nonresidential construction have corresponded ...
Breaking Medicine News(10 mins):Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Living Well Joins San Rafael Chamber of Commerce 2Health News:Living Well Joins San Rafael Chamber of Commerce 3Health News:Long-acting insulin is safer, more effective for patients with Type 1 diabetes 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 4
Other TagsOther Tags